renato-valenti documents

DIREZIONE STUDIO STUDIO Il naturale integratore per lo studio Gestione pratiche, stato avanzamento lavori, recupero redditività
Documents DIREZIONE STUDIO STUDIO Il naturale integratore per lo studio Gestione pratiche, stato avanzamento lavori, recupero redditività
Non è accogliente Destinazioni, alberghi, ristoranti, uffici informazioni turistiche e musei… non accoglienti
Documents Non è accogliente Destinazioni, alberghi, ristoranti, uffici informazioni turistiche e musei… non accoglienti
Comparison of Everolimus-Eluting Stent With Paclitaxel-Eluting Stent in Long Chronic Total Occlusions
Documents Comparison of Everolimus-Eluting Stent With Paclitaxel-Eluting Stent in Long Chronic Total Occlusions
TCT-51 Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry
Documents TCT-51 Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry
TCT-442 The Impact of High Residual Platelet Reactivity After Clopidogrel Loading on Cardiac Mortality in Patients Treated by Percutaneous Coronary Intervention for Chronic Total Occlusion
Documents TCT-442 The Impact of High Residual Platelet Reactivity After Clopidogrel Loading on Cardiac Mortality in Patients Treated by Percutaneous Coronary Intervention for Chronic Total Occlusion
TCT-726 Residual Platelet Reactivity Threshold After Clopidogrel Loading Dose to Predict Long-term Clinical Outcome in Patients with Acute Coronary Syndrome: Insights from the RECLOSE2-ACS
Documents TCT-726 Residual Platelet Reactivity Threshold After Clopidogrel Loading Dose to Predict Long-term Clinical Outcome in Patients with Acute Coronary Syndrome: Insights from the RECLOSE2-ACS
Clinical and Angiographic Outcomes of Patients Treated With Everolimus-Eluting Stents or First-Generation Paclitaxel-Eluting Stents for Unprotected Left Main Disease
Documents Clinical and Angiographic Outcomes of Patients Treated With Everolimus-Eluting Stents or First-Generation Paclitaxel-Eluting Stents for Unprotected Left Main Disease
TCT-443 Predictors of Reocclusion After Successful Drug-Eluting Stent Supported Percutaneus Coronary Intervention for Chronic Total Occlusion
Documents TCT-443 Predictors of Reocclusion After Successful Drug-Eluting Stent Supported Percutaneus Coronary Intervention for Chronic Total Occlusion